The new doll will include an insulin pump, a glucose monitor, and a dress featuring international symbols for diabetes ...

TPN-101, a potent nucleoside reverse transcriptase inhibitor that specifically inhibits the LINE-1 reverse transcriptase.

Marcel Botha discusses ways the agency can ensure it gets the most accurate results possible from AI.

Renee Gala named next CEO of Jazz Pharmaceuticals: Gala will take over as president and CEO on August 11, 2025, following ...

Approval was based on results from the Phase IIIb TRAILBLAZER-ALZ 6 trial, which showed that Kisunla achieved comparable ...

Life sciences marketing has long revolved around physicians. Traditionally seen as the gatekeepers of prescribing power, ...

ADRX-0405 is uniquely being tested during its 1a/b clinical trials. ADRX-0405 is labeled as a STEAP1 ADC (primarily ...

Accelerated approval was based on results from the Phase I/II LINKER-MM1 trial, which showed a 70% objective response rate in ...

Biljana Naumovic, US President, oncology, solid tumor, Johnson & Johnson Innovative Medicine, outlines how the company is ...

Varda Space Industries announced its Series C fundraiser for medicine creation in space has reached $187 million. This now ...

While the growing oncology pipeline offers tremendous potential, the path from clinical development through to commercial ...

In today’s fast-paced, innovation-fueled biopharma landscape, the traditional model of C-suite leadership is being turned on ...